Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide and topiramate combination therapy for chronic migraine
IRCT20190804044429N9Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lacosamide and topiramate in chronic migraine, sponsored by Mazandaran University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
lacosamidetopiramate
03
Conditions
chronic migraine
Beyond the preview
Go deeper on IRCT20190804044429N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N9.